Huamao Wang

Huamao Wang

UNVERIFIED PROFILE

Are you Huamao Wang?   Register this Author

Register author
Huamao Wang

Huamao Wang

Publications by authors named "Huamao Wang"

Are you Huamao Wang?   Register this Author

19Publications

436Reads

49Profile Views

Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma.

J Immunol 2019 07 29;203(1):198-207. Epub 2019 May 29.

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200032, China; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1800033DOI Listing
July 2019

Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer.

J Natl Cancer Inst 2019 04;111(4):409-418

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy134DOI Listing
April 2019

Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bitargeted Chimeric Antigen Receptor T Cell.

Cancer Immunol Res 2018 11 10;6(11):1314-1326. Epub 2018 Sep 10.

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
http://cancerimmunolres.aacrjournals.org/lookup/doi/10.1158/
Publisher Site
http://dx.doi.org/10.1158/2326-6066.CIR-18-0044DOI Listing
November 2018

Species-Specific Involvement of Integrin αIIbβ3 in a Monoclonal Antibody CH12 Triggers Off-Target Thrombocytopenia in Cynomolgus Monkeys.

Mol Ther 2018 06 7;26(6):1457-1470. Epub 2018 Apr 7.

Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2018.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986981PMC
June 2018

Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager.

Oncotarget 2017 Aug 16;8(32):52866-52876. Epub 2017 May 16.

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.17905DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581077PMC
August 2017

EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer.

Mol Cancer 2017 07 19;16(1):127. Epub 2017 Jul 19.

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, No.25/Ln2200, XieTu Road, Shanghai, 200032, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-017-0704-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518108PMC
July 2017

Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma.

Cancer Immunol Immunother 2017 Apr 29;66(4):475-489. Epub 2016 Dec 29.

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln2200, XieTu Road, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-016-1949-8DOI Listing
April 2017

Anti-angiogenesis through noninvasive to minimally invasive intraocular delivery of the peptide CC12 identified by in vivo-directed evolution.

Biomaterials 2017 01 30;112:218-233. Epub 2016 Sep 30.

Department of Ophthalmology, Shanghai Key Laboratory of Fundus Disease, Shanghai General Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200080, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2016.09.022DOI Listing
January 2017

The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.

Cancer Lett 2014 Jan 2;342(1):113-20. Epub 2013 Sep 2.

State Key Laboratory of Oncogenes & Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2013.08.038DOI Listing
January 2014

Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.

Oncol Rep 2012 Oct 8;28(4):1453-60. Epub 2012 Aug 8.

Department of Oncology, Affiliated Hospital of Qingdao University, Medical College, Qingdao, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2012.1960DOI Listing
October 2012

Bioprocess development for the production of mouse-human chimeric anti-epidermal growth factor receptor vIII antibody C12 by suspension culture of recombinant Chinese hamster ovary cells.

Cytotechnology 2011 May 5;63(3):247-58. Epub 2011 Feb 5.

State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, P.O. box 329, 130 Meilong Rd., 200237, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10616-011-9336-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081043PMC
May 2011

Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III.

J Biol Chem 2011 Feb 16;286(7):5913-20. Epub 2010 Dec 16.

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Medical School of Shanghai Jiaotong University, Shanghai 200032, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M110.192252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037704PMC
February 2011

Identification and characterization of Ch806 mimotopes.

Cancer Immunol Immunother 2010 Oct 11;59(10):1481-7. Epub 2010 Jun 11.

Shanghai Medical College, Fudan University, No. 130, Dong'an Road, Shanghai, 200032, China.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00262-010-0872
Web Search
http://link.springer.com/10.1007/s00262-010-0872-7
Publisher Site
http://dx.doi.org/10.1007/s00262-010-0872-7DOI Listing
October 2010

A novel gene delivery system targeting Tie2 for cancer gene therapy.

Anticancer Res 2010 Jun;30(6):1999-2004

Department of Medical Oncology, Cancer Hospital of Fudan University, Department of Oncology, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
June 2010

Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy.

Acta Biochim Biophys Sin (Shanghai) 2008 Mar;40(3):217-25

Department of Medical Oncology, Cancer Hospital of Fudan University, Shanghai 200032, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1745-7270.2008.00389.xDOI Listing
March 2008

A novel small peptide as a targeting ligand for receptor tyrosine kinase Tie2.

Biochem Biophys Res Commun 2004 Mar;315(4):1004-10

National Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao-Tong University Medical School, Shanghai 200032, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2004.01.157DOI Listing
March 2004